Form 8-K - Current report:
SEC Accession No. 0001193125-24-270280
Filing Date
2024-12-04
Accepted
2024-12-04 06:04:52
Documents
13
Period of Report
2024-11-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d877669d8k.htm   iXBRL 8-K 24955
  Complete submission text file 0001193125-24-270280.txt   147283

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mtem-20241127.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtem-20241127_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtem-20241127_pre.xml EX-101.PRE 11256
16 EXTRACTED XBRL INSTANCE DOCUMENT d877669d8k_htm.xml XML 3674
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

EIN.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 241524666
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)